相关实验视频

Updated: Mar 17, 2026

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

针对TREM2来解开神经炎症和帕金森病中的α-Syn病理传播

Yixu Chen¹, Hao Wang¹, Jun Wang¹

¹Institute for Brain Sciences Research, School of Life Sciences, Henan University, Kaifeng 475004, China.

Cellular signalling

|March 16, 2026

概括

在骨髓细胞2 (TREM2) 上表达的触发受体在帕金森病 (PD) 发病过程中起着关键作用. 了解TREM2的复杂功能为PD精度治疗提供了新的途径.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
遗传学遗传学是一个

背景情况:

帕金森病 (PD) 涉及多巴胺基神经元损失和α-synuclein聚合.
神经炎症和遗传因素在很大程度上导致了PD的发病.
TREM2是一个关键的微质调节器,与PD有关.

研究的目的:

系统地审查TREM2的结构,信号和PD中的作用.
详细阐述TREM2在PD病理生理学中的多维功能.
分析TREM2变体,环境相互作用和PD的治疗策略.

主要方法:

对TREM2分子机制和信号通路的系统审查.
对遗传关联研究和PD模型中的功能角色的分析.
评估TREM2对α-synuclein代谢,神经炎症和神经元生存的影响.

主要成果:

在PD中,TREM2信号调节微质功能,α-synuclein清除和炎症反应.
TREM2基因变异与PD风险相关,并影响疾病的进展.
在神经炎症和多巴胺基神经元保护中,TREM2表现出双重作用.

结论:

TREM2是PD的关键参与者,影响α-synuclein病理,神经炎症和神经元生存.
准TREM2通路为PD精度治疗提供了一个有希望的策略.
对TREM2变体和微环境相互作用的进一步研究对于推进PD治疗至关重要.

关键词:

微质细胞中的微质细胞神经炎症是一种神经炎症.帕金森病的疾病.在TREM2中,我们可以使用TREM2.α-Synuclein 是一种同核蛋白.

更多相关视频

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...